Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07785154

A Registry-study of ELZONRIS in Participants With BPDCN

Sponsor: Stemline Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

The main goal of this registry study is to investigate the effectiveness and safety of tagraxofusp in the treatment of adult participants with BPDCN in the real-world clinical practice setting.

Official title: Post-Authorisation Registry of ELZONRIS (Tagraxofusp) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2024-06-26

Completion Date

2030-06

Last Updated

2026-08-25

Healthy Volunteers

No

Interventions

DRUG

Tagraxofusp

No study medication will be provided by the sponsor during this study.

Locations (41)

Medical University Innsbruck

Innsbruck, Austria

Ordensklinikum Linz Krankenhaus der Elisabethinen Linz

Linz, Austria

Salzburg Cancer Research Institute (SCRI)

Salzburg, Austria

Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology

Vienna, Austria

Universitätsklinikum Augsburg

Augsburg, Germany

Hospital Bielefeld

Bielefeld, Germany

Klinikum Chemnitz

Chemnitz, Germany

University Clinic of Frankfurt

Frankfurt, Germany

University clinic of Freiburg

Freiburg im Breisgau, Germany

Universitätsmedizin Halle

Halle, Germany

Asklepios Hamburg

Hamburg, Germany

University Medical Center Hamburg - Eppendorf

Hamburg, Germany

Community Hospital Kiel

Kiel, Germany

Universitätsklinikum Leipzig Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

Leipzig, Germany

Universitätsklinikum Schleswig-Holstein

Lübeck, Germany

Technical University of Munich

Munich, Germany

Oldenburgh

Oldenburg, Germany

Medizinische Klinik Universitat Tübingen

Tübingen, Germany

AON SS Antonio e Biagio e C Arrigo Alessandria SOC Ematologia

Alessandria, Italy

AOU di Bologna - Policlinico S. Orsola-Malpighi - UOC Ematologia

Bologna, Italy

CTC U.O di Ematologia con Trapianto di Midollo Osseo - Catania

Catania, Italy

ASO S. Croce e Carle - Cuneo - SC Ematologia

Cuneo, Italy

AOU Arcispedale Sant'Anna Cona (FE) - UOC Ematologia e Fisiopatologia della Coagulazione

Ferrara, Italy

AOU Careggi - Firenze - SOD Ematologia

Florence, Italy

IRCCS AOU San Martino - Genova - UO Clinica Ematologica

Genova, Italy

UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino - Genoa

Genova, Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Milano - Ematologia

Milan, Italy

SC Ematologia - ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy

AOU Federico II - UOC Ematologia e Trapianti di Midollo

Naples, Italy

AOU di Padova - UO Ematologia

Padova, Italy

AO Ospedali Riuniti Villa Sofia Cervello Palermo - UO Ematologia con UTMO

Palermo, Italy

Fondazione IRCCS Policlinico San Matteo Pavia UO Ematologia

Pavia, Italy

AO di Perugia, Ospedale S. Maria della Misericordia - Ematologia E Trapianto Midollo Osseo

Perugia, Italy

ASL Pescara - Presidio Ospedaliero "Spirito Santo" - UOC Ematologia Clinica

Pescara, Italy

AOU Policlinico Tor Vergata - Roma - Ematologia

Roma, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Roma - Area Ematologica

Roma, Italy

AOU 'San Giovanni di Dio e Ruggi d'Aragona' Salerno - UOC Ematologia

Salerno, Italy

AOU Città della Salute e della Scienza - Ospedale S. G. Battista Molinette - Torino - SC Ematologia

Torino, Italy

ASUI di Udine - Presidio Ospedaliero "Santa Maria della Misericordia" - Clinica Ematologica

Udine, Italy

Insel Gruppe AG, Bern University Hospital

Bern, Switzerland

Luzerner Kantonsspital

Lucerne, Switzerland